Form 8-K - Current report:
SEC Accession No. 0000950170-25-087885
Filing Date
2025-06-18
Accepted
2025-06-18 16:06:05
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K aura-20250617.htm   iXBRL 8-K 67876
  Complete submission text file 0000950170-25-087885.txt   179890

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20250617.xsd EX-101.SCH 27223
12 EXTRACTED XBRL INSTANCE DOCUMENT aura-20250617_htm.xml XML 4925
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 251056928
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)